WHO releases new guidelines on hepatitis B
In a landmark move, the World Health Organization (WHO) has released groundbreaking guidelines to address the global challenge of chronic hepatitis B (HBV) infection. Unveiled at the 2024 Asian Pacific Conference for the Study of Liver Disease in Kyoto, Japan, these guidelines aim to simplify and expand access to HBV testing and treatment, marking a crucial step towards the WHO's goal...
In a landmark move, the World Health Organization (WHO) has released groundbreaking guidelines to address the global challenge of chronic hepatitis B (HBV) infection.
Unveiled at the 2024 Asian Pacific Conference for the Study of Liver Disease in Kyoto, Japan, these guidelines aim to simplify and expand access to HBV testing and treatment, marking a crucial step towards the WHO's goal of eliminating viral hepatitis by 2030. With over 250 million people worldwide living with HBV, the new WHO guidelines focus on preventing mother-to-child transmission, a key transmission route, by recommending antiviral treatment for pregnant women and immediate newborn vaccination. This approach not only aims to reduce the global burden of HBV but also prevents liver-related complications, aligning with India's efforts to curb the disease through its Universal Immunization Program (UIP).
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd